Blinky
Motivational AI companion that celebrates wins and keeps users on track
Software · Cloud SaaSCompany source
Company profile
About Simple
Simple is a health technology company that provides an AI-powered weight loss and wellness coaching app designed to help users achieve sustainable weight loss and healthier lifestyles. The company's approach centers on behavior change rather than restrictive dieting, combining intermittent fasting guidance, nutrition education, and personalized coaching through its award-winning AI coach, Avo. Simple's platform includes features such as a food scanner with smart feedback, personalized fasting schedules, activity tracking for Pilates, yoga, and walking, and hydration monitoring. The app is distinguished by its dual-coach system: Avo, the empathetic AI coach that adapts plans in real-time and provides personalized daily actions, and Blinky, a motivational companion that celebrates wins and keeps users accountable. Simple's methodology prioritizes safety and sustainability, teaching users to meet nutritional needs and develop long-term healthy habits without calorie counting, eliminating food groups, or weighing food. The company has helped users collectively lose over 20 million pounds and serves millions of users globally. Simple offers both free and premium subscription tiers, with the premium version unlocking personalized daily check-ins, educational content, and advanced coaching features. All content is grounded in evidence-based science and reviewed by nutrition and health experts.
Company description Simple official website
Primary marketMetabolic Health & Nutrition
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Simple?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- General wellness
- Metabolic health
- Obesity
- Overweight
- PCOS weight management
Who it serves
- Individual consumers
- Intermittent fasting practitioners
- People with PCOS
- Weight loss seekers
- Wellness-focused individuals
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsGlobal (multi-language support suggests international presence) · United States
Company sourceOfficial website
Company milestones
Platform expansion
Raised $35 million in funding (October 2025); Users collectively lost 20 million pounds (February 2026); Won silver at Digital Health Awards 2026 in Mobile Applications category (June 2026); Won MedTech Breakthrough Award for Best Virtual Coach for second consecutive year (April 2026); Launched Blinky motivational companion and Success Score feature (November 2025)
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Coach Avo
Award-winning humanlike AI coach for personalized health guidance
Software · Cloud SaaSCompany source
Simple Success Score
Science-backed metric tracking overall health progress
Software · Cloud SaaSCompany source
Simple: Weight Loss & Health Coaching App
AI-powered weight loss and health coaching app with personalized guidance
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Integrating delivery systems and microenvironmental cues to accelerate clinical translation of cardiac reprogramming.Materials today. Bio · Oct 1, 2026
IL-5 Biology and Eosinophil Regulation: Advances, Resistance Pathways and Future Directions.Respiratory medicine · Aug 31, 2026
Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs).Naunyn-Schmiedeberg's archives of pharmacology · Aug 22, 2026
Human neuronal cells SH-SY5Y as an in vitro model to study Neospora caninum infection and innate immune modulation.Veterinary journal (London, England : 1997) · Aug 5, 2026
Exploring how patients, caregivers and clinicians experience pain across therapeutic areas in Italy: a multi-centre narrative medicine project.BMJ open · Jul 30, 2026
Within-Provider Variation in Prices for Commonly Utilized Services in Office Setting: Cross-Sectional Study.Interactive journal of medical research · Jul 23, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
20 million pounds lost collectively
Total weight loss across all Simple users as of February 2026
Trusted by millions
Total app downloads and active users
Average user testimonials show 10-76 lbs lost
Individual user success stories featured on homepage
Simple Users (Aggregate)
Weight loss through Simple app usage
20 million pounds lost collectively by Simple users
Debi
Comprehensive health tracking including water, food, and fasting
Lost 76 pounds and gained control over health
James
Weight loss through honest food tracking and app feedback
Lost 30 pounds with helpful feedback from the app
Joelle
Mindful eating and meal planning transformation
Lost 50 pounds and developed new perspective on eating habits
Lori
Sustainable weight loss through delayed gratification approach
Lost 73 pounds using mindful eating strategies
Teresa
Weight loss and improved energy through Simple app
Lost 10 pounds and one pant size, gained more energy and mental clarity
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Trey Reck
Content Writer/Team Member
06 · Company updates
Updates from Simple
Recent articles published on Simple's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
India Rewrites the Rulebook for Stem Cell Therapies and Essential Drug Pricing in Landmark Healthcare Reform
New regulatory framework brings gene and cell therapies under formal oversight while controversial pricing changes could reshape access to essential medicines
Policy & Regulation · Jul 3, 2026
Cancer's Escape Route: How Tumors Outsmart Billion-Dollar Blood Vessel Drugs
KAIST researchers reveal the molecular mechanism behind anti-VEGF therapy resistance, pointing toward AI-driven combination treatments that could finally stop cancer's vascular hijacking.
Clinical AI · Jul 3, 2026
Healthcare's AI Darwinism: Why Most Hospitals Will Fail the Autonomous Revolution
Healthcare organizations face mounting pressure to adopt autonomous AI systems or risk competitive obsolescence in what industry observers describe as a technological survival test.
Clinical AI · Jun 16, 2026
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Metabolic Health & Nutrition
Companies using AI to optimize metabolic health, provide personalized nutrition recommendations, or analyze metabolic responses to food for generally healthy or non-diabetic populations. Emphasizes wellness, performance optimization, and preventive health rather than management of a diagnosed disease.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.